Found 8 matching trials
Bioavailability Study of 10 Milligram (mg) and 5 mg Tablets Versus Conventional Tablets of Dolutegravir PHASE1 The aim of this cross-over study is to compare the relative bioavailability...
Show More Location
GSK Investigational Site
Learn More & Join Trial
To Assess the Relative Bioavailability (BA) of TRIUMEQ® and Dolutegravir and Lamivudine (DTG/3TC) Pediatric Dispersible Tablet Formulations in Healthy Volunteers PHASE1 This is a 2-part, single-dose, open label, randomized 3-way cross-over stud...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1 PHASE1 The purpose of this study was to evaluate the safety, tolerability, and pha...
Show More Location
USC - Maternal Child Adolescent/Adult Center
Learn More & Join Trial
Relative Bioavailability Study of a Fixed-dose Combination Dolutegravir/Abacavir/Lamivudine Dispersible Tablet PHASE1 This is an open-label, randomized, crossover study in healthy adult subject...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Abacavir, Dolutegravir and Lamivudine Dispersible Tablets (60 mg/5 mg/30 mg) EARLY_PHASE1 The rationale for this study is to evaluate and understand the variability ...
Show More Learn More & Join Trial
A Food-effect Study of the Pediatric Dispersible Tablet Formulations of TRIUMEQ® and DOVATO® in Healthy Adult Participants PHASE1 This study will assess the effect of food on the pharmacokinetics (PK) of p...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Relative Bioavailability Study to Investigate a Potential Interaction Between DTG DT and F/TAF TOS. PHASE1 This relative bioavailability (RBA) study will be conducted to investigate ...
Show More Learn More & Join Trial
Dolutegravir Pediatric Liquid Formulation Study PHASE1 This is an open-label, single-center, single dose, non-randomized, sequenti...
Show More Location
GSK Investigational Site
Learn More & Join Trial